Ekaterina Zelenkova

Stellar Pharmaceuticals Inc. (USA) (OTC:SLXCF) Stock Collapses

by Ekaterina Zelenkova November 11, 2010

In a press release,  WPI Executive Vice President, Global Brands stated: "at this time we do not plan to allocate any additional resources to further pursue this development program."

SLXCF_from_the_site.pngStellar Pharmaceuticals Inc. currently markets Uracyst directly in Canada and through license agreements in Denmark, Sweden, Norway, Finland, Iceland, the UK, Republic of Ireland, the Netherlands, Italy, Turkey, Portugal and Spain.

In addition to the United States, the company has licensing agreements in place for its product Uracyst in Israel, South Korea and China, territories which are all currently awaiting regulatory approval.

Type the characters that you see in the box (5 characters).